.avif)
Learn how Canadian private funds use GP-led continuation vehicles to create LP liquidity, extend asset holds and finance future growth.
A private equity fund can reach the later years of its life while still owning a business the GP does not want to sell.
The company may still have meaningful growth ahead. The IPO market may be unattractive. A strategic sale may undervalue the business. Yet some limited partners may want distributions rather than another extension.
A GP-led continuation vehicle can separate those two decisions.
Instead of forcing every investor to sell or remain invested, the sponsor can transfer one or more portfolio companies from the legacy fund into a newly created vehicle. Existing LPs generally receive an opportunity to take cash or continue their exposure, while new secondary investors provide capital for the transaction.
The concept is straightforward. Executing it fairly is not.
Quick Answer: A GP-led continuation vehicle lets a Canadian private fund transfer one or more portfolio companies into a new vehicle managed by the same sponsor. Existing LPs can typically sell for cash or roll into the new fund, while secondary investors provide fresh capital. It makes sense when a strong asset needs more time, but pricing and conflicts must be carefully managed.
A continuation vehicle, or CV, is a new investment vehicle established to acquire one or more assets from an existing fund while the same GP continues managing those assets.
Canadian law firm Osler describes the basic structure this way: portfolio companies move from an existing fund into a newly formed vehicle funded by a combination of rolling LPs and new secondary investors. Existing investors are typically offered the choice to receive cash or roll their exposure into the new vehicle. Read Osler's July 2026 Canadian continuation-vehicle guidance.
Continuation vehicles can be:
The transaction sits within the broader GP-led secondary market.
Unlike a normal third-party sale, however, the sponsor is effectively involved on both sides. The GP manages the fund selling the asset and will usually manage the vehicle buying it.
That conflict is the central structural issue.
The strongest reason is usually that LP liquidity needs and the optimal exit date for the portfolio company no longer match.
Suppose a private equity fund is approaching the end of its stated term.
It owns a portfolio company that has:
Some LPs may still want their capital returned.
Others may prefer to retain exposure.
The continuation vehicle lets those investors make different decisions.
Osler notes that Canadian sponsors increasingly view CVs both as a liquidity solution for older funds and as a way to continue holding high-conviction assets where a conventional exit may be premature.
That does not mean a CV is automatically preferable to a sale.
The GP should be able to explain exactly why another three, four or five years of ownership is expected to create value.
"We do not want to sell yet" is not a sufficient investment thesis.
New secondary capital effectively finances the cash-out election.
Consider a legacy fund that owns a portfolio company valued at CAD $300 million.
Instead of selling the company to a strategic buyer, the GP establishes a continuation vehicle.
Existing LPs are offered two basic options.
A selling LP elects to receive cash based on the transaction price.
A rolling LP exchanges or reinvests its economic exposure into the continuation vehicle and participates in the next phase of ownership.
New secondary investors contribute capital to finance the LPs choosing liquidity.
Additional capital can also be raised for:
This is fundamentally different from simply extending the existing fund.
An extension preserves the legacy fund structure.
A continuation transaction establishes a new economic arrangement with a new investment period, new investors and potentially new management fees, carried-interest terms, governance rights and financing.
Because the GP wants two things that can pull in opposite directions.
As manager of the selling legacy fund, the GP should want the highest defensible value for exiting investors.
As manager of the continuation vehicle, it also wants an attractive entry point from which the new vehicle can generate future returns.
Osler identifies conflicts of interest as the principal risk in CV transactions because the sponsor acts for the seller while continuing as manager of the buyer.
The Institutional Limited Partners Association makes the same issue central to its continuation-fund guidance.
As of September 2026, ILPA says continuation vehicles have become an established private-markets liquidity tool but emphasizes conflicts management, defensible pricing, process integrity, disclosure and meaningful LP engagement. Its 2026 revised guidance was still being finalized after public consultation, while ILPA's previously published guidance remained relevant. See ILPA's current Continuation Vehicles resources.
The practical implication is simple:
The GP should be able to show how the price was discovered, not merely state what it believes the asset is worth.
Ideally through a process capable of producing a defensible market price.
Depending on the situation, that can include:
Osler notes that fairness opinions and independent valuation reports can be particularly useful in single-asset transactions, non-competitive processes or situations involving significant valuation judgment.
A fairness opinion does not eliminate the GP's conflict.
Neither does an LPAC vote.
These are parts of a broader process designed to make the economics supportable.
The transaction becomes much more difficult to defend if the sponsor values an asset aggressively when reporting to existing LPs and then immediately transfers it to a vehicle it controls at a materially lower price without a credible explanation.
A genuine decision.
LPs typically need enough information and time to compare selling against rolling.
The analysis may include:
The objective should not be to design a nominal "choice" in which one alternative is economically impractical.
ILPA's guidance focuses heavily on enabling informed investor elections through standardized information, early engagement and transparent treatment of the inherent conflict.
The GP should also review side letters.
Different LPs may have:
Those rights do not disappear simply because the fund is nearing the end of its life.
It becomes a significant negotiation point.
The original fund may have created substantial unrealized value.
The GP may therefore have accrued carry associated with that appreciation.
At the same time, new secondary investors are entering at the newly established transaction value and expect the GP to earn future incentive compensation based on additional value created after their investment.
Issues can include:
Osler notes that carry crystallization, management fees, reset hurdles, waterfalls and sponsor commitments are commonly heavily negotiated.
If the GP's thesis is that significant value remains, rolling meaningful economics alongside LPs can strengthen alignment.
Equity from secondary investors is usually central, but the financing stack can be broader.
Depending on the transaction, sources could include:
This is where the distinction between fund liquidity and portfolio-company liquidity matters.
If the portfolio company itself can prudently refinance existing obligations or raise growth capital, that capital may belong at the operating company rather than the fund.
For example, a Canadian portfolio business may be able to use private credit, asset-based lending, or mezzanine financing to support its own capital needs.
The GP should not automatically place debt at the continuation-vehicle level just because the CV can borrow.
The debt should sit where the repayment source makes the most sense.
Potentially.
A continuation vehicle owning a valuable portfolio could potentially add a NAV-style or HoldCo financing layer to supplement investor equity.
That may reduce the immediate equity cheque required from secondary buyers.
It also adds leverage to equity that may already sit above leveraged portfolio companies.
That layering matters.
Suppose the operating company already has CAD $120 million of senior debt.
The CV then incurs another CAD $40 million of fund-level debt.
A deterioration in enterprise value hits the equity layer before operating-company senior debt. The CV lender's effective protection can therefore weaken quickly.
For Canadian private-credit structures generally, Mehmi's private-credit guide explains why security, covenants, cash sweeps and repayment strategy matter in addition to the headline interest rate.
Where debt is being used only as a temporary bridge to an expected secondary closing or asset realization, the same principle described in Mehmi's commercial bridge financing guide applies: the lender needs a credible exit.
The companion guide to how Canadian bridge lenders assess cash flow, collateral and repayment is useful when determining whether the financing is solving a timing issue or simply postponing a permanent capital problem.
Assume a Canadian PE fund owns a portfolio company with an agreed equity value of CAD $300 million.
The GP believes another four years of ownership could create significant value.
Existing LP elections are:
The continuation vehicle also needs:
The transaction therefore represents CAD $330 million of total economic uses.
One hypothetical capital structure could include:
The cash sources are CAD $240 million.
Those funds cover:
Assume the CAD $40 million CV-level facility carries an illustrative fixed rate of 9.5%, paid quarterly on an interest-only basis for three years, with a 1.5% upfront fee.
Quarterly cash interest would equal approximately CAD $950,000.
Annual cash interest would be CAD $3.8 million.
If the entire CAD $40 million remained outstanding for three years, total cash interest would equal CAD $11.4 million.
The 1.5% financing fee would equal CAD $600,000.
The full CAD $40 million principal would still have to be repaid at maturity, creating total principal, interest and assumed upfront-fee cash requirements of approximately CAD $52 million over the three-year period.
The practical question is therefore not merely whether debt lets the secondary investors contribute CAD $40 million less equity at closing.
It is whether portfolio distributions, a refinancing or an eventual asset sale can reliably provide CAD $3.8 million of annual interest plus the CAD $40 million maturity obligation.
The example excludes legal, tax, fund-administration, valuation, advisory and other costs and does not represent a Mehmi Financial Group financing offer or market quote.
Sometimes.
If the actual problem is that LPs need a modest distribution rather than a complete liquidity option, refinancing the portfolio company may be simpler.
A company that has materially grown and deleveraged might potentially raise new capital and distribute some of the proceeds upstream.
That should be assessed cautiously because it raises portfolio-company leverage.
Mehmi's guide to how refinancing works explains the basic credit discipline: a new facility should improve the capital structure rather than simply replace one obligation with another.
Asset-heavy portfolio companies may also have financing capacity outside ordinary cash-flow debt.
Owned machinery can potentially support equipment refinancing or a sale-leaseback.
Businesses with substantial receivables may be able to finance working capital separately through invoice factoring, allowing permanent acquisition or recapitalization debt to focus on long-term uses.
These are alternatives to evaluate, not reasons to lever an operating business merely to avoid a continuation transaction.
A conventional sale transfers the asset to a genuinely different owner.
A continuation transaction generally preserves GP control while changing the investor base and resetting the investment horizon.
That is why a CV should not automatically be described as an "exit."
Selling LPs obtain liquidity.
Rolling LPs do not.
The GP continues managing the asset.
For portfolio companies that are actually ready for a third-party sale, a proper M&A process may provide cleaner price discovery. Mehmi's Canadian M&A financing guide explains the financing side of operating-company acquisitions, although institutional continuation transactions require materially more complex fund, tax and governance work.
A CV is most persuasive when the sponsor can explain why continued ownership is commercially superior to a normal sale at that point in time.
Do not assume moving an investment from one fund vehicle to another is automatically tax-deferred.
The result depends on what is being transferred, the legal entities involved, where investors reside, the consideration received and how the rollover is structured.
Canada's Income Tax Act contains rollover mechanisms for certain qualifying transfers. CRA notes, for example, that section 85 can permit eligible property to be transferred to a taxable Canadian corporation at an elected amount, while subsection 97(2) addresses qualifying transfers to Canadian partnerships. The requirements are specific and should not be assumed to apply to a particular CV transaction. See CRA's guidance on transfers of capital property.
A continuation transaction may also involve:
Osler recommends involving tax advisers during initial planning rather than attempting to repair the structure after LP elections have been collected.
Potentially.
Moving an operating company from a legacy fund to a continuation vehicle can still require Canadian competition analysis.
Osler notes that sponsors should assess whether mandatory pre-merger notification under the Competition Act applies. It also notes that where the existing fund and continuation vehicle are legal affiliates within the meaning of the Act, an affiliate exemption can apply. The exact ownership and transaction architecture therefore matters. Read Osler's Canadian competition-law analysis for continuation vehicles.
The potential application of the Investment Canada Act may also need to be assessed depending on the investors and structure.
These are legal questions for transaction counsel, not assumptions to make from the portfolio company's purchase price alone.
Yes.
One recent example involved Canadian sponsor Novacap.
In September 2025, Novacap completed a continuation-vehicle transaction involving Canadian insurance managing general agent Revau. The new vehicle was backed by a consortium that included Northleaf Capital Partners, Export Development Canada, Fonds de solidarité FTQ and other institutional investors. Willkie described it as Novacap's fourth continuation vehicle overall and the first for its Financial Services strategy. See the transaction announcement.
The example is useful because it shows that continuation vehicles are not merely a U.S. market concept imported into Canadian terminology.
They are being used in Canadian institutional private-equity transactions.
A CV is strongest when there is a good asset with a timing problem.
That may mean:
A continuation vehicle is much weaker when it is being used mainly because the GP cannot sell an underperforming company at its carrying value.
Moving an asset from Fund I to another GP-controlled vehicle does not repair weak economics.
Consider the alternatives before launching a full CV process.
A fund-term extension may be cleaner if nearly all LPs want to remain invested.
A third-party sale may make more sense if genuine strategic buyers will pay an attractive price.
A portfolio-company recapitalization may work if the only goal is a modest amount of liquidity.
Fund-level preferred equity or debt may solve a temporary cash need.
A secondary sale of individual LP interests can create liquidity without moving the underlying company.
And if the portfolio company itself needs capital for an acquisition, financing that transaction directly may be more appropriate than restructuring the entire fund.
The correct structure solves the actual liquidity problem with the fewest unnecessary conflicts and layers of capital.
It is generally a finite-life fund approaching its stated termination date or extension period while still holding unrealized investments. "Aging" does not necessarily mean the assets are distressed. A fund may simply own companies that require more time than originally anticipated.
Not necessarily. A common feature of GP-led continuation transactions is a sell-or-roll election, allowing some LPs to receive cash while others retain exposure through the new vehicle. Exact rights depend on the fund documents and negotiated transaction structure.
Typically, yes. Continued GP ownership and management is one of the defining characteristics of a continuation vehicle.
The process varies. Secondary investors may provide bids, a lead investor may negotiate pricing, and independent valuation or fairness work may supplement the process. Because the GP is conflicted, credible price discovery is particularly important.
Potentially. Fund-level, NAV, HoldCo or other structured financing may be possible depending on the assets, fund documents, cash flows and lender requirements. Borrowing adds another layer of risk and should have a clear repayment source.
Yes. A CV can be structured not only to cash out selling LPs but also to provide additional capital for acquisitions, expansion, deleveraging or other parts of the next-stage investment thesis.
Not automatically. Canadian rollover provisions may be available in particular structures, but eligibility depends on the transaction. Selling and rolling LPs can also have different tax consequences. Canadian tax counsel should be involved before finalizing the structure or election mechanics.
The inherent conflict between the GP's role in selling the asset for the legacy fund and its role managing the acquiring vehicle. Strong valuation support, transparent disclosures, LPAC engagement, fair elections and meaningful GP alignment help manage that conflict but do not eliminate it.
If you are evaluating a GP-led continuation vehicle or another fund-liquidity transaction, prepare the financing amount, Canadian province and fund jurisdiction, portfolio assets involved, estimated NAV or transaction value, proposed use of funds, existing portfolio-company debt, LP liquidity requirement and transaction timing.
Mehmi Financial Group operates as a financing brokerage and intermediary, not a direct lender. For large or specialized transactions, Mehmi can review whether institutional private credit, fund-level debt, asset-backed financing or another specialty-capital structure may be relevant. Legal, tax, fund-governance and valuation advice should be provided by the appropriate professional advisers, and all financing remains subject to participating capital providers' underwriting and approval.
Call 833-863-4644 or use the Mehmi Financial Group contact page to discuss the capital requirement.
.svg){kind=small}